Showing 1,881 - 1,900 results of 74,799 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.45s Refine Results
  1. 1881
  2. 1882
  3. 1883
  4. 1884
  5. 1885

    Minimal underlying data set. by Machiko K. Asaka (18334223)

    Published 2024
    “…This investigation involved measurement using the Mullen Scale of Early Learning in a representative sample of Japanese infants followed up from the age of 0 to 2 years (Nishimura et al., 2016). In the present study, we investigated the potential association between cytokine concentrations in umbilical cord serum with any of the five classes of neurodevelopmental trajectories previously assigned, as follows: high normal (N = 85, 13.0%), normal (N = 322, 49.1%), low normal (N = 137, 20.9%), delayed (N = 87, 13.3%), and markedly delayed (N = 25, 3.8%) in infancy. …”
  6. 1886
  7. 1887

    rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death. by Helen P. McWilliams-Koeppen (116503)

    Published 2015
    “…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”
  8. 1888
  9. 1889
  10. 1890
  11. 1891

    Decreased diaphragm muscle axonal branching distance, bifurcations and neuromuscular junctions in GAD67-deficient (−/−) E18.5 mice. by Matthew J. Fogarty (283288)

    Published 2013
    “…C and D show significant decreases in the number of medial and lateral axonal branches (mean ± SEM) respectively at discrete distances away from main nerve trunk in GAD67-deficient (red) mice compared to wild type controls (blue). …”
  12. 1892
  13. 1893

    Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
  14. 1894
  15. 1895
  16. 1896
  17. 1897
  18. 1898
  19. 1899
  20. 1900